A Meta-Analysis of the Efficacy of Donepezil, Rivastigmine, Galantamine, and Memantine in Relation to Severity of Alzheimer's Disease
Author:
Affiliation:
1. Fondazione IRCCS “Santa Lucia”, Roma, Italy
2. Istituto di Tecnologie Biomediche – Consiglio Nazionale delle Ricerche, Segrate (MI), Italy
3. Università degli Studi di Roma “Tor Vergata”, Roma, Italy
Publisher
IOS Press
Subject
Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience
Cited by 140 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems;AAPS PharmSciTech;2024-09-05
2. Potential therapeutic natural compounds for the treatment of Alzheimer's disease;Phytomedicine;2024-09
3. Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023;Frontiers in Pharmacology;2024-07-17
4. Peripheral inflammation as a potential mechanism and preventive strategy for perioperative neurocognitive disorder under general anesthesia and surgery;Frontiers in Cellular Neuroscience;2024-07-03
5. Development of novel fluoro-substituted rivastigmine derivatives as selective AChE inhibitors for the treatment of AD;Medicinal Chemistry Research;2024-06-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3